Related article in
-
ArticleJune 30, 1992
0
1145
166
Molecular Biologic Analysis of Human Leukemias - Diagnosis of Leukemia by Protooncogene -
Chul Shin Park, Hwan Jung Yun, Eui Gun Chun, Jung Young Kil, Deog Yeon Jo, Samyong Kim, Bok Su Lee, Sang Gi Paik
Korean J Hematol 1992; 27(2): 273-282 -
ArticleMarch 31, 1993
0
649
289
Detection of BCR - ABL Gene Rearrangement by Use of the Polymerase Chain Reaction in Chronic Myeloid Leukemia
Joon Sik Kim, Jeong Hee Kim, Wan Gyu Uh, Sun Hee Kim, Si Young Kim, Hwi Joong Yoon, Kyung Sam Cho
Korean J Hematol 1993; 28(1): 71-80 -
ArticleJune 30, 1994
0
155
44
A Case of Chronic Neutrophilic Leukemia
Mi Kyung Chang, Nan Hee Kim, Kyung Muk Choi, Jin Goo Lee, Yong Jin Nam, Sang Won Shin, Jun Suk Kim, Bo Ra Son, Gap No Lee
Korean J Hematol 1994; 29(2): 223-228 -
ArticleSeptember 30, 2001
0
656
227
Pattern of Telomerase Activities in Acute Leukemias and Chronic Myeloid Leukemia
Myeong You Kim, Jeong Nyeo Lee
Korean J Hematol 2001; 36(3): 189-196 -
ArticleJune 30, 2003
0
506
172
Retrospective Analysis of Prognostic Factors Affecting Survival After Onset of Blastic Crisis of Chronic Myeloid Leukemia Especially Focused on FAB Classification
Ho Jin Shin, Joo Seop Chung, Eun Yup Lee, Jae Seok Kim, Hyo Jin Kim, Won Sik Lee, Chang Hak Sohn, Goon Jae Cho
Korean J Hematol 2003; 38(2): 119-126 -
Case ReportMarch 30, 2009
0
1406
139
Complete Hematologic Response and Cytogenetic Remission after Imatinib and Dexamethasone Treatment of a Ph+ Precursor B-cell Acute Lymphoblastic Leukemia in Renal Transplantation Patient
Sun Kyung Baek, Kyung Sam Cho, Byung Hyuk Yang, Si Young Kim, Hwi Joong Yoon, Kyung hwan Jeong, Chun Gyoo Ihm
Korean J Hematol 2009; 44(1): 62-65 -
Original ArticleJune 23, 2016
4
2642
542
A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea
Shuhua Li, Hyeon-Ho Lim, Kwang-Sook Woo, Sung-Hyun Kim, and Jin-Yeong Han
Blood Res 2016; 51(2): 122-126 -
Case ReportJune 25, 2014
5
3424
617
A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow
Young Jae Byun, Byeong-Bae Park, Eun Sung Lee, Kyung Soo Choi, and Dae Sung Lee
Blood Res 2014; 49(2): 127-129 -
Case ReportMarch 31, 2010
13
1441
170
A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate
Min Sik Kim, Dong Hyun Lee, Yu Rim Lee, Dong Kyun Kim, Suk Hyang Bae, Jin Yeon Hwang, Kyung A Kwon, Suee Lee, Jin Yeong Han, Ki Uk Kim, and Sung-Hyun Kim
Korean J Hematol 2010; 45(1): 73-75 -
Review ArticleJune 30, 2010
3
1221
57
JAK2 V617F and the evolving paradigm of polycythemia veraRobert T. Means Jr
Korean J Hematol 2010; 45(2): 90-94 -
Original ArticleJune 22, 2017
1
4308
1279
Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia
Swati Dasgupta, Ujjal K Ray, Arpita Ghosh Mitra, Deboshree M. Bhattacharyya, Ashis Mukhopadhyay, Priyabrata Das, Sudeshna Gangopadhyay, Sudip Roy, and Soma Mukhopadhyay
Blood Res 2017; 52(2): 112-118 -
Original ArticleMarch 31, 2018
10
2713
1118
Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia
Tae Yang Song, Sang Hoon Lee, Gun Kim, Hee Jo Baek, Tai Ju Hwang, and Hoon Kook
Blood Res 2018; 53(1): 25-34 -
Original ArticleMarch 31, 2018
7
2666
554
Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East
Akbar Safaei, Ahmad Monabati, Moeinadin Safavi, Ali Atashabparvar, and Marzieh Hosseini
Blood Res 2018; 53(1): 49-52 -
Original ArticleJune 25, 2018
1
1908
1432
Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis
Nadia El-Menshawy, Sherin M. Abd-Aziz, Enas M Elkhamisy, and Mohammed A. Ebrahim
Blood Res 2018; 53(2): 138-144 -
Original ArticleMarch 31, 2019
6
6559
1633
Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission
Juae Shin, Na Yeong Lee, Seongkoo Kim, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, and Bin Cho
Blood Res 2019; 54(1): 45-51 -
Original ArticleMarch 31, 2019
5
2535
651
ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
Ahmed M. L. Bedewy, Shereen M. Elmaghraby, and Noha S. Kandil
Blood Res 2019; 54(1): 57-62 -
Original ArticleSeptember 30, 2020
5
4238
855
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
Maria Gemelli, Elena Maria Elli, Chiara Elena, Alessandra Iurlo, Tamara Intermesoli, Margherita Maffioli, Ester Pungolino, Maria Cristina Carraro, Mariella D’Adda, Francesca Lunghi, Michela Anghileri, Nicola Polverelli, Marianna Rossi, Mattia Bacciocchi, Elisa Bono, Cristina Bucelli, Francesco Passamonti, Laura Antolini, Carlo Gambacorti-Passerini
Blood Res 2020; 55(3): 139-145 -
Original ArticleMarch 31, 2021
2
3487
648
Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey
Jieun Uhm, Kyoung Ha Kim, Hyewon Lee, Hawk Kim, Slader Cassandra, Inkyung Joo, Chul Won Jung
Blood Res 2021; 56(1): 31-37 -
Review ArticleApril 30, 2021
7
4962
1168
Disease modifying agents of myeloproliferative neoplasms: a review
Sung-Eun Lee
Blood Res 2021; 56(S1): S26-S33 -
Review ArticleDecember 31, 2021
21
5590
1028
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res 2021; 56(4): 229-242 -
Original ArticleJune 30, 2022
3
2907
464
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, Inho Kim, June-Won Cheong, Won Sik Lee, Byung Soo Kim, Deog-Yeon Jo, Chul Won Jung, Chu Myoung Seong, Jae Hoon Lee, Young Jin Yuh, Min Kyoung Kim, Hun-Mo Ryoo, Moo-Rim Park, Su-Hee Cho, Hoon-Gu Kim, Dae Young Zang, Jinny Park, Hawk Kim, Seryeon Lee, Sung-Hyun Kim, Myung Hee Chang, Ho Sup Lee, Chul Won Choi, Jihyun Kwon, Sung-Nam Lim, Suk-Joong Oh, Inkyung Joo, Dong-Wook Kim
Blood Res 2022; 57(2): 144-151 -
Review ArticleApril 30, 2023
6
3093
962
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res 2023; 58(S1): S29-S36 -
Review ArticleApril 30, 2023
2
2073
627
Prognostication in myeloproliferative neoplasms, including mutational abnormalities
Junshik Hong
Blood Res 2023; 58(S1): S37-S45 -
Review ArticleApril 30, 2023
5
3161
767
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res 2023; 58(S1): S58-S65 -
Review ArticleApril 30, 2023
1
1308
365
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
Blood Res 2023; 58(S1): S109-S113
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
Young Hoon Park, Dae-Young Kim, Seongkoo Kim, Young Bae Choi, Dong-Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung-Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook, on behalf of Korean Aplastic Anemia Working Party
Blood Res 2022;57: 20-28 -
Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
Blood Res 2022;57: S79-S85
Most Cited
-
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res 2022;57: S32-S36 -
Basic immunohistochemistry for lymphoma diagnosis
Junhun Cho
Blood Res 2022;57: S55-S61
Editorial Office
+82-2-516-6582
